Literature DB >> 8595803

Neuropsychological test performance, cognitive functioning, blood pressure, and age: the Framingham Heart Study.

M F Elias1, R B D'Agostino, P K Elias, P A Wolf.   

Abstract

Interactions of three indices of blood pressure (systolic blood pressure, diastolic blood pressure, and chronicity of hypertension) and age-cohort membership were examined for a sample of 1,695 stroke-free participants of the Framingham Heart Study, ages 55-88 years. Blood pressure level and chronicity of hypertension were assessed over five biennial examinations performed between 1956 and 1964, a time when few hypertensives were being treated, and were related to neuropsychological tests administered between 1976 and 1978. Multiple linear regression methods were used to examine Age x Blood Pressure (or Chronicity of Hypertension) interactions in alternative analyses involving three age groups (55-64 years, 65-74 years, and 75-88 years) and age as a continuously distributed variable (age in years). Interactions were either statistically nonsignificant or trivial with respect to magnitude of effect. This was true when interaction terms (Age x Blood Pressure Level or Age x Chronicity of Hypertension) were controlled for blood pressure, age, education, occupation, cigarette smoking, alcohol consumption, gender, and antihypertensive treatment. The Age x Blood Pressure model as it pertains to older adults was not supported, but independent associations (with all covariables controlled) between the indices of blood pressure and cognitive functioning were statistically significant.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8595803     DOI: 10.1080/03610739508253991

Source DB:  PubMed          Journal:  Exp Aging Res        ISSN: 0361-073X            Impact factor:   1.645


  23 in total

1.  Vascular and cognitive functions associated with cardiovascular disease in the elderly.

Authors:  Ronald A Cohen; Athena Poppas; Daniel E Forman; Karin F Hoth; Andreana P Haley; John Gunstad; Angela L Jefferson; David F Tate; Robert H Paul; Lawrence H Sweet; Mokato Ono; Beth A Jerskey; Marie Gerhard-Herman
Journal:  J Clin Exp Neuropsychol       Date:  2008-06-16       Impact factor: 2.475

Review 2.  Are cognitive function and blood pressure related?

Authors:  M Viitanen; Z Guo
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

Review 3.  BioAge: toward a multi-determined, mechanistic account of cognitive aging.

Authors:  Correne A DeCarlo; Holly A Tuokko; Dorothy Williams; Roger A Dixon; Stuart W S MacDonald
Journal:  Ageing Res Rev       Date:  2014-09-30       Impact factor: 10.895

Review 4.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

5.  The effects of transcranial LED therapy (TCLT) on cerebral blood flow in the elderly women.

Authors:  Afonso S I Salgado; Renato A Zângaro; Rodolfo B Parreira; Ivo I Kerppers
Journal:  Lasers Med Sci       Date:  2014-10-03       Impact factor: 3.161

6.  Arterial pulse wave velocity and cognition with advancing age.

Authors:  Merrill F Elias; Michael A Robbins; Marc M Budge; Walter P Abhayaratna; Gregory A Dore; Penelope K Elias
Journal:  Hypertension       Date:  2009-02-23       Impact factor: 10.190

Review 7.  Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline.

Authors:  Paul K Crane; Kaavya Narasimhalu; Laura E Gibbons; Dan M Mungas; Sebastien Haneuse; Eric B Larson; Lewis Kuller; Kathleen Hall; Gerald van Belle
Journal:  J Clin Epidemiol       Date:  2008-05-05       Impact factor: 6.437

8.  Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study.

Authors:  Christopher B Brady; J Michael Gaziano; Roberta A Cxypoliski; Peter D Guarino; James S Kaufman; Stuart R Warren; Pamela Hartigan; David S Goldfarb; Rex L Jamison
Journal:  Am J Kidney Dis       Date:  2009-07-23       Impact factor: 8.860

Review 9.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

10.  Higher blood pressure predicts lower regional grey matter volume: Consequences on short-term information processing.

Authors:  Peter J Gianaros; Phil J Greer; Christopher M Ryan; J Richard Jennings
Journal:  Neuroimage       Date:  2006-02-20       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.